Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.
J L Moake, … , L H Nolasco, J D Hellums
J L Moake, … , L H Nolasco, J D Hellums
Published December 1, 1986
Citation Information: J Clin Invest. 1986;78(6):1456-1461. https://doi.org/10.1172/JCI112736.
View: Text | PDF
Research Article Article has an altmetric score of 9

Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.

  • Text
  • PDF
Abstract

A fluid shear stress of 180 dyn/cm2 was applied for 0.5 and 5 min to platelets in citrated plasma or blood in a cone and plate viscometer with minimal platelet-surface interactions. Platelets aggregated in the shear field if large von Willebrand Factor (vWF) multimers were present. Aggregation did not require ristocetin, other exogenous agents, or desialation of vWF. Unusually large vWF multimers produced by human endothelial cells were functionally more effective than the largest plasma vWF forms in supporting shear-induced aggregation. Shear-induced aggregation was inhibited by monoclonal antibodies to platelet glycoprotein Ib or the IIb/IIIa complex, but was little affected by the absence of fibrinogen. vWF-dependent platelet aggregation under elevated shear stress in partially occluded vessels of the arterial microcirculation may contribute to thrombosis, especially if unusually large vWF multimers are released locally from stimulated or disrupted endothelial cells.

Authors

J L Moake, N A Turner, N A Stathopoulos, L H Nolasco, J D Hellums

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1969 Total
Citations: 1 4 3 6 11 13 8 5 10 15 14 15 10 8 10 8 10 9 15 8 17 20 23 18 29 19 7 17 12 13 13 9 8 14 7 6 8 3 1 1 428
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (429)

Title and authors Publication Year
RalB uncoupling from exocyst is required for endothelial Weibel-Palade body exocytosis
Yang M, Boye-Doe A, Ali M, Abosabie SA, Barr AM, Mendez LM, Sharda AV
Molecular Biology of the Cell 2025
Management of Portal Hypertension in Patients with Hepatocellular Carcinoma on Systemic Treatment: Current Evidence and Future Perspectives
De Gaetano V, Pallozzi M, Cerrito L, Santopaolo F, Stella L, Gasbarrini A, Ponziani FR
Cancers 2024
Platelet Biorheology and Mechanobiology in Thrombosis and Hemostasis: Perspectives from Multiscale Computation
Tuna R, Yi W, Crespo Cruz E, Romero J, Ren Y, Guan J, Li Y, Deng Y, Bluestein D, Liu ZL, Sheriff J
International journal of molecular sciences 2024
RalB uncoupled exocyst mediates endothelial Weibel-Palade body exocytosis
Yang M, Boye-Doe A, Abosabie SA, Barr AM, Mendez LM, Sharda AV
bioRxiv 2024
Complement-mediated hemolytic uremic syndrome associated with postpartum hemorrhage: case series and systematic review of individual participant data
Gurevich-Shapiro A, Orbach-Zinger S, Leader A, Stemer G, Wiznitzer A, Singer P, Davidovits M, Shapiro M, Hamulyák EN, Raanani P, Spectre G
Research and Practice in Thrombosis and Haemostasis 2024
The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure.
Takaya H, Namisaki T, Enomoto M, Kubo T, Tsuji Y, Fujinaga Y, Nishimura N, Kaji K, Kawaratani H, Moriya K, Akahane T, Matsumoto M, Yoshiji H
Biology 2023
A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpura.
Falter T, Rossmann H, de Waele L, Dekimpe C, von Auer C, Müller-Calleja N, Häuser F, Degreif A, Marandiuc D, Messmer X, Sprinzl M, Lackner KJ, Jurk K, Vanhoorelbeke K, Lämmle B
Blood Advances 2023
Clearance of VWF by hepatic macrophages is critical for the protective effect of ADAMTS13 in sickle cell anemia mice
Shi H, Gao L, Kirby N, Shao B, Shan X, Kudo M, Silasi R, McDaniel JM, Zhou M, McGee S, Jing W, Lupu F, Cleuren A, George JN, Xia L
Blood 2023
Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications
Z Ma, KY Yang, Y Huang, KO Lui
Journal of Molecular and Cellular Cardiology 2022
COVID-19 and thrombosis: The role of hemodynamics.
Sastry S, Cuomo F, Muthusamy J
Thrombosis Research 2022
Influence of Shear Stress, Inflammation and BRD4 Inhibition on Human Endothelial Cells: A Holistic Proteomic Approach.
Jarausch J, Neuenroth L, Andag R, Leha A, Fischer A, Asif AR, Lenz C, Eidizadeh A
Cells 2022
Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis.
Reuken PA, Brozat JF, Quickert S, Ibidapo-Obe O, Reißing J, Franz A, Stengel S, Teichgräber UK, Kiehntopf M, Trautwein C, Stallmach A, Koch A, Bruns T
Journal of Intensive Care 2022
von Willebrand factor links primary hemostasis to innate immunity.
Drakeford C, Aguila S, Roche F, Hokamp K, Fazavana J, Cervantes MP, Curtis AM, Hawerkamp HC, Dhami SPS, Charles-Messance H, Hackett EE, Chion A, Ward S, Ahmad A, Schoen I, Breen E, Keane J, Murphy R, Preston RJS, O'Sullivan JM, Sheedy FJ, Fallon P, O'Donnell JS
Nature Communications 2022
Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease.
Gritsch H, Schrenk G, Weinhappl N, Mellgård B, Ewenstein B, Turecek PL
Journal of blood medicine 2022
Point-of-Care Diagnostic Assays and Novel Preclinical Technologies for Hemostasis and Thrombosis
C Caruso, WA Lam
Seminars in thrombosis and hemostasis 2021
Changes in Maternal Platelet Physiology during Gestation and Their Interaction with Trophoblasts
D Forstner, J Guettler, M Gauster
International journal of molecular sciences 2021
Loss of Stability of the Blood Liquid State and Assessment of Shear-Induced Thrombosis Risk
DM Pushin, TY Salikhova, LS Biryukova, GT Guria
RADIOPHYS QUANT EL+ 2021
A 1D–3D Hybrid Model of Patient-Specific Coronary Hemodynamics
NG Gutiérrez, T Sinno, SL Diamond
Cardiovascular Engineering and Technology 2021
Hematologic Findings in Pregnancy: A Guide for the Internist
P Patel, N Balanchivadze
Cureus 2021
The force awakens: The dark side of mechanosensing in bacterial pathogens
J Mordue, N O'Boyle, N Gadegaard, AJ Roe
Cellular Signalling 2021
More than a Feeling: Microscopy Approaches to Understanding Surface-Sensing Mechanisms
KJ Graham, LL Burrows, W Margolin
Journal of bacteriology 2021
Application of a Simple Microfluidic Chip Analysis Technology to Evaluate the Inhibitory Role of Protocatechuic Acid on Shear-Induced Platelet Aggregation
C He, L Yu, W Dan, S Deng, H Ma, B Liu, Y Li, MH Hashempur
Evidence-Based Complementary and Alternative Medicine 2021
Portal Hypertension - Recent Advances
X Qi
2021
Microangiopatías trombóticas primarias: una revisión narrativa
N Henao-Piedrahita
2021
Shrinking Weibel-Palade bodies prevents high platelet recruitment in assays using thrombotic thrombocytopenic purpura plasma.
Patella F, Vendramin C, Charles O, Scully MA, Cutler DF
Research and Practice in Thrombosis and Haemostasis 2021
Diverse activities of von Willebrand factor in traumatic brain injury and associated coagulopathy
X Xu, R Kozar, J Zhang, J Dong
Journal of Thrombosis and Haemostasis 2020
Animal models of thrombotic thrombocytopenic purpura: the tales from zebrafish
P Coppo, B Lämmle
Haematologica 2020
Thrombocytopenia-Associated Multiple Organ Failure
TC Nguyen
Critical Care Clinics 2020
Platelet activation via dynamic conformational changes of von Willebrand factor under shear
DM Pushin, TY Salikhova, KE Zlobina, GT Guria, AV Panfilov
PloS one 2020
Association between ADAMTS13 activity–VWF antigen imbalance and the therapeutic effect of HAIC in patients with hepatocellular carcinoma
H Takaya, T Namisaki, K Moriya, N Shimozato, K Kaji, H Ogawa, K Ishida, Y Tsuji, D Kaya, H Takagi, Y Fujinaga, N Nishimura, Y Sawada, H Kawaratani, T Akahane, M Matsumoto, H Yoshiji
World journal of gastroenterology : WJG 2020
Disappearance of Angiodysplasia Following Transcatheter Aortic Valve Implantation in a Patient with Heyde's Syndrome: A Case Report and Review of the Literature
S Tsuchiya, Y Matsumoto, T Doman, T Fujiya, J Sugisawa, A Suda, K Sato, S Ikeda, T Shindo, Y Kikuchi, K Hao, J Takahashi, W Hatta, T Koike, A Masamune, Y Saiki, H Horiuchi, H Shimokawa
Journal of Atherosclerosis and Thrombosis 2020
Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute Phase
S Sakurai, H Kato, Y Yoshida, Y Sugawara, M Fujisawa, A Yasumoto, M Matsumoto, Y Fujimura, Y Yatomi, M Nangaku
Journal of Atherosclerosis and Thrombosis 2020
Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink
N Morici, M Bottiroli, R Fumagalli, C Marini, M Cattaneo
Thrombosis and Haemostasis 2020
Results of extended phenotyping of von Willebrand disease in the remote diagnostic program in children
AV Poletaev, EA Seregina, AV Pshonkin, NA Karamyan, DV Fedorova, PA Zharkov
2020
Fluctuating neurological symptoms: should I call the neurologist or the hematologist?
R Losa-Rodríguez, CP Martínez, GR Pérez, I de la Fuente Graciani, LM García
2020
Between a Rock and a Hard Place: How to Use Antithrombotics in Patients Undergoing Transcatheter Aortic Valve Replacement
K Grossman, MR Williams, H Ibrahim
2020
Clínica neurológica fluctuante: ¿Llamo al neurólogo o al hematólogo?
R Losa-Rodríguez, CP Martínez, GR Pérez, I de la Fuente Graciani, LM García
2020
Relationship of Thrombospondin 1 to von Willebrand Factor and ADAMTS-13 in Sickle Cell Disease Patients of Arab Ethnicity
A Al-Awadhi, A Adekile, R Marouf
Acta Haematologica 2020
Force-Regulated Refolding of the Mechanosensory Domain in the Platelet Glycoprotein Ib-IX Complex
XF Zhang, W Zhang, ME Quach, W Deng, R Li
Biophysical Journal 2019
Hemodynamic variables in aneurysms are associated with thrombotic risk in children with Kawasaki disease
NG Gutierrez, M Mathew, BW McCrindle, JS Tran, AM Kahn, JC Burns, AL Marsden
International Journal of Cardiology 2019
Acquired von Willebrand Syndrome in Patients With Ventricular Assist Device
A Rauch, S Susen, B Zieger
Frontiers in Medicine 2019
ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma
H Takaya, T Namisaki, N Shimozato, K Kaji, M Kitade, K Moriya, S Sato, H Kawaratani, T Akahane, M Matsumoto, H Yoshiji
World journal of gastrointestinal oncology 2019
Clinical features and prognosis of patients with thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a review of 25 cases
J Li, JJ Jiang, CY Wang, S Jian, Y Zhou, MS Ma, XY Tang, L Wang, MY Quan, Y Zhang, J Xiao, YY He, HM Song
Italian Journal of Pediatrics 2019
Biomarkers associating endothelial Dysregulation in pediatric-onset systemic lupus erythematous
WF Lee, CY Wu, HY Yang, WI Lee, LC Chen, LS Ou, JL Huang
Pediatric Rheumatology 2019
Preprocedural P2Y 12 inhibition and decrease in platelet count following transcatheter aortic valve replacement
H Ibrahim, E Vapheas, B Shah, A AlKhalil, M Querijero, H Jilaihawi, P Neuburger, C Staniloae, MR Williams
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2019
Acquired von Willebrand syndrome in patients treated with veno-arterial extracorporeal membrane oxygenation
T Tamura, H Horiuchi, Y Obayashi, M Fuki, M Imanaka, M Kuroda, S Nishimura, M Amano, J Sakamoto, Y Tamaki, S Enomoto, M Miyake, H Kondo, C Izumi, Y Nakagawa
Cardiovascular Intervention and Therapeutics 2019
Current and future antiplatelet therapies: emphasis on preserving haemostasis
JD McFadyen, M Schaff, K Peter
Nature Reviews Cardiology 2018
von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C
H Takaya, H Kawaratani, Y Tsuji, K Nakanishi, S Saikawa, S Sato, Y Sawada, K Kaji, Y Okura, N Shimozato, M Kitade, T Akahane, K Moriya, T Namisaki, A Mitoro, M Matsumoto, H Fukui, H Yoshiji
United European gastroenterology journal 2018
Validation of PLASMIC score and follow-up data in a cohort of patients with suspected microangiopathies from Southern Italy
GL Tiscia, A Ostuni, N Cascavilla, F Cappucci, P Scalzulli, C Battista, A Abrescia, F Aucella, C Buquicchio, M Brigante, G DAndrea, BD Paolo, G Giordano, B Infante, S Piano, P Ranieri, L Tullo, E Grandone
Journal of Thrombosis and Thrombolysis 2018
Immune Hematology
JM Despotovic
2018
Von Willebrand factor and the aortic valve: Concepts that are important in the transcatheter aortic valve replacement era
H Ibrahim, MT Rondina, NS Kleiman
Thrombosis Research 2018
The Von Willebrand Factor A1–Collagen III Interaction Is Independent of Conformation and Type 2 Von Willebrand Disease Phenotype
VR Machha, A Tischer, L Moon-Tasson, M Auton
Journal of Molecular Biology 2017
Modeling thrombus formation and growth: Modeling Thrombus Formation and Growth
H Hosseinzadegan, DK Tafti
Biotechnology and Bioengineering 2017
Margination and stretching of von Willebrand factor in the blood stream enable adhesion
K Rack, V Huck, M Hoore, DA Fedosov, SW Schneider, G Gompper
Scientific Reports 2017
Decreased ADAMTS-13 level is related to inflammation factors and risk stratification of acute lymphoblastic leukemia patients:
C Liu, L Zhao, J Zhao, Q Xu, Y Song, H Wang
Medicine 2017
Decreased activity of plasma ADAMTS13 are related to enhanced cytokinemia and endotoxemia in patients with acute liver failure
H Takaya, H Yoshiji, H Kawaratani, K Sakai, M Matsumoto, Y Fujimura, H Fukui
Biomedical Reports 2017
Shear-mediated platelet activation in the free flow: Perspectives on the emerging spectrum of cell mechanobiological mechanisms mediating cardiovascular implant thrombosis
MJ Slepian, J Sheriff, M Hutchinson, P Tran, N Bajaj, JG Garcia, SS Saavedra, D Bluestein
Journal of Biomechanics 2017
Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
A Michels, LL Swystun, J Mewburn, S Albánez, D Lillicrap
Journal of visualized experiments : JoVE 2017
Effect of aorto-iliac bifurcation and iliac stenosis on flow dynamics in an abdominal aortic aneurysm
S Patel, AY Usmani, K Muralidhar
Fluid Dynamics Research 2017
Platelet hyperaggregability is associated with decreased ADAMTS13 activity and enhanced endotoxemia in patients with acute cholangitis: ADAMTS13 and endotoxin in acute cholangitis
H Takaya, H Kawaratani, T Kubo, K Seki, Y Sawada, K Kaji, Y Okura, K Takeda, M Kitade, K Moriya, T Namisaki, A Mitoro, M Matsumoto, H Fukui, H Yoshiji
Hepatology Research 2017
A Two-phase mixture model of platelet aggregation
J Du, AL Fogelson
Mathematical Medicine and Biology 2017
Platelet clearance via shear-induced unfolding of a membrane mechanoreceptor
W Deng, Y Xu, W Chen, DS Paul, AK Syed, MA Dragovich, X Liang, P Zakas, MC Berndt, JD Paola, J Ware, F Lanza, CB Doering, W Bergmeier, XF Zhang, R Li
Nature Communications 2016
Update on ADAMTS13 and VWF in cardiovascular and hematological disorders
O Akyol, S Akyol, CH Chen
Clinica Chimica Acta 2016
Analysis of risk factor and clinical characteristics of angiodysplasia presenting as upper gastrointestinal bleeding
DB Kim, WC Chung, SJ Lee, HJ Sung, S Woo, HS Kim, YO Jeong, H Lee, YJ Kim
The Korean Journal of Internal Medicine 2016
Thiol–Disulfide Exchange Reactions in the Mammalian Extracellular Environment
MC Yi, C Khosla
Annual Review of Chemical and Biomolecular Engineering 2016
Acquired von Willebrand syndrome associated with left ventricular assist device
A Nascimbene, S Neelamegham, OH Frazier, JL Moake, J Dong
Blood 2016
A mechanistic investigation of thrombotic microangiopathy associated with IV abuse of Opana ER
R Hunt, A Yalamanoglu, J Tumlin, T Schiller, JH Baek, A Wu, AB Fogo, H Yang, E Wong, P Miller, PW Buehler, C Kimchi-Sarfaty
Blood 2016
Regulation of VWF expression, and secretion in health and disease:
Y Xiang, J Hwa
Current Opinion in Hematology 2016
Transport physics and biorheology in the setting of hemostasis and thrombosis
LF Brass, SL Diamond
Journal of Thrombosis and Haemostasis 2016
Aqueous outflow - A continuum from trabecular meshwork to episcleral veins
T Carreon, E der Merwe, RL Fellman, M Johnstone, SK Bhattacharya
Progress in Retinal and Eye Research 2016
Structural basis for the specific inhibition of glycoprotein Ibα shedding by an inhibitory antibody
Y Tao, X Zhang, X Liang, J Zang, X Mo, R Li
Scientific Reports 2016
Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study
S Lancellotti, M Basso, V Veca, M Sacco, L Riccardi, M Pompili, RD Cristofaro
Internal and Emergency Medicine 2016
Platelet activation risk index as a prognostic thrombosis indicator
KE Zlobina, GT Guria
Scientific Reports 2016
Association of Nasal Mucosal Vascular Alterations, Gastrointestinal Arteriovenous Malformations, and Bleeding in Patients With Continuous Flow Left Ventricular Assist Devices
SR Patel, S Madan, O Saeed, M Algodi, A Luke, M Gibber, DJ Goldstein, UP Jorde
JACC: Heart Failure 2016
Pharmacokinetics, efficacy, and safety of a plasma-derived VWF/FVIII concentrate (VONCENTO) for on-demand and prophylactic treatment in patients with von Willebrand disease (SWIFT-VWD study):
TJ Lissitchkov, E Buevich, K Kuliczkowski, O Stasyshyn, MH Cerqueira, A Klukowska, C Joch, W Seifert
Blood Coagulation & Fibrinolysis 2016
Neutralization of inhibitory antibodies and restoration of therapeutic ADAMTS-13 activity levels in inhibitor-treated rats by the use of defined doses of recombinant ADAMTS-13
B Plaimauer, A Schiviz, S Kaufmann, W Höllriegl, H Rottensteiner, F Scheiflinger
Journal of Thrombosis and Haemostasis 2015
“Do-it-yourself in vitro vasculature that recapitulates in vivo geometries for investigating endothelial-blood cell interactions”
RG Mannino, DR Myers, B Ahn, Y Wang, M Rollins, H Gole, AS Lin, RE Guldberg, DP Giddens, LH Timmins, WA Lam
Scientific Reports 2015
Fluid Mechanics of Blood Clot Formation
AL Fogelson, KB Neeves
Annual Review of Fluid Mechanics 2015
Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury
TC Nguyen, MA Cruz, JA Carcillo
Critical Care Clinics 2015
Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis
BR Branchford, CJ Ng, KB Neeves, JD Paola
Thrombosis Research 2015
Significant Association between Serum Levels of Von Willebrand Factor (vWF) Antigen with Stages of Cirrhosis
VT Yilmaz, D Dincer, AB Avci, R Cetinkaya
The Eurasian Journal of Medicine 2015
The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis
R Groot, DA Lane, JT Crawley
Blood 2015
Diagnostic approach to von Willebrand disease
C Ng, DG Motto, JD Paola
Blood 2015
Pathological von Willebrand factor fibers resist tissue plasminogen activator and ADAMTS13 while promoting the contact pathway and shear-induced platelet activation
BA Herbig, SL Diamond
Journal of Thrombosis and Haemostasis 2015
Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate
JJ Goldberger, R Arora, D Green, P Greenland, DC Lee, DM Lloyd-Jones, M Markl, J Ng, SJ Shah
Circulation 2015
High Flow Velocity Through Congenital Cardiac Lesions Predicts Preoperative Platelet Dysfunction
MM Zubair, AR Hohimer, DK Bailly, A Muralidaran, EJ Madriago, MH Zubair, MR Lasarev, SM Langley
The Annals of Thoracic Surgery 2015
Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury
TC Nguyen, MA Cruz, JA Carcillo
Critical Care Clinics 2015
Reduced ADAMTS13 activity is associated with thrombotic risk in systemic lupus erythematosus
S Martin-Rodriguez, JC Reverter, D Tàssies, G Espinosa, M Heras, M Pino, G Escolar, M Diaz-Ricart
Lupus 2015
Identification of a juxtamembrane mechanosensitive domain in the platelet mechanosensor glycoprotein Ib-IX complex
W Zhang, W Deng, L Zhou, Y Xu, W Yang, X Liang, Y Wang, JD Kulman, XF Zhang, R Li
Blood 2014
ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies
G Sarig
Rambam Maimonides Medical Journal 2014
Guía diagnóstica y terapéutica de las microangiopatías trombóticas del Grupo Español de Aféresis
E Contreras, J la Rubia, J Río-Garma, M Díaz-Ricart, JM García-Gala, M Lozano
Medicina Clínica 2014
Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis
M Stockschlaeder, R Schneppenheim, U Budde
Blood Coagulation & Fibrinolysis 2014
Hemostasis and Thrombosis: Practical Guidelines in Clinical Management
EX Stavrou, AH Schmaier
Hemostasis and Thrombosis: Practical Guidelines in Clinical Management 2014
Treatment of mechanical aortic valve thrombosis with heparin and eptifibatide
AN Vora, T Gehrig, TM Bashore, TL Kiefer
Journal of Thrombosis and Thrombolysis 2014
Platelet expression of stromal cell-derived factor-1 is associated with the degree of valvular aortic stenosis
T Wurster, R Tegtmeyer, O Borst, D Rath, T Geisler, M Gawaz, B Bigalke
PloS one 2014
Bioengineering in Platelet Biology
R Flaumenhaft
Thrombosis Research 2014
How I treat type 2 variant forms of von Willebrand disease
A Tosetto, G Castaman
Blood 2014
Surface attachment induces Pseudomonas aeruginosa virulence
A Siryaporn, SL Kuchma, GA O’Toole, Z Gitai
Proceedings of the National Academy of Sciences 2014
Pathobiology of Human Disease
S Akilesh
Pathobiology of Human Disease 2014
Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis
PA Reuken, A Kussmann, M Kiehntopf, U Budde, A Stallmach, RA Claus, T Bruns
Liver International 2014
Pediatric Critical Care Medicine
JL Wynn, JA Hazelzet, TP Shanley, HR Wong, DS Wheeler
Pediatric Critical Care Medicine 2014
Platelet Expression of Stromal Cell-Derived Factor-1 Is Associated with the Degree of Valvular Aortic Stenosis
T Wurster, R Tegtmeyer, O Borst, D Rath, T Geisler, M Gawaz, B Bigalke, I Ahrens
PloS one 2014
Evaluation of a disintegrin-like and metalloprotease with thrombospondin type 1 repeat motifs 13 (ADAMTS13) activity enzyme-linked immunosorbent assay for measuring plasma ADAMTS13 activity in dogs
H Maruyama, M Kaneko, T Otake, R Kano, Y Yamaya, T Watari, A Hasegawa, H Kamata
Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 2014
Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy
R Tati, AC Kristoffersson, A Ståhl, J Rebetz, L Wang, C Licht, D Motto, D Karpman
Journal of immunology (Baltimore, Md. : 1950) 2013
HUS and TTP in Children
H Trachtman
Pediatric Clinics of North America 2013
Handbook of Proteolytic Enzymes
FS Markland, S Swenson
Handbook of Proteolytic Enzymes 2013
Mechanical Activation of a Multimeric Adhesive Protein Through Domain Conformational Change
SS Wijeratne, E Botello, HC Yeh, Z Zhou, AL Bergeron, EW Frey, JM Patel, L Nolasco, NA Turner, JL Moake, J Dong, CH Kiang
Physical Review Letters 2013
A three-dimensional co-culture model of the aortic valve using magnetic levitation
H Tseng, LR Balaoing, B Grigoryan, RM Raphael, TC Killian, GR Souza, KJ Grande-Allen
Acta Biomaterialia 2013
Review article: gastrointestinal angiodysplasia - pathogenesis, diagnosis and management
SS Sami, SA Al-Araji, K Ragunath
Alimentary Pharmacology & Therapeutics 2013
ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatment: ADAMTS13 Unbound to Larger VWF Multimers in Cryosupernatant
Y Hori, M Hayakawa, A Isonishi, K Soejima, M Matsumoto, Y Fujimura
Transfusion 2013
Mechanical Activation of a Multimeric Adhesive Protein through Domain Conformational Change
SS Wijeratne, E Botello, HC Yeh, Z Zhou, A Bergeron, EW Frey, JM Patel, J Moake, J Dong, CH Kiang
Physical Review Letters 2013
Maladies rares en médecine d’urgence
YE Claessens, L Mouthon
2013
A three-dimensional co-culture model of the aortic valve using magnetic levitation.
Tseng H, Balaoing LR, Grigoryan B, Raphael RM, Killian TC, Souza GR, Grande-Allen KJ
Acta Biomaterialia 2013
Multiscale Systems Biology and Physics of Thrombosis Under Flow
MH Flamm, SL Diamond
Annals of Biomedical Engineering 2012
Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura
P Coppo, A Veyradier
La Presse Médicale 2012
Thrombotic microangiopathies: From empiricism to targeted therapies
P Coppo
La Presse Médicale 2012
Multiscale prediction of patient-specific platelet function under flow
MH Flamm, TV Colace, MS Chatterjee, H Jing, S Zhou, D Jaeger, LF Brass, T Sinno, SL Diamond
Blood 2012
Indications for a protective function of beta2-glycoprotein I in thrombotic thrombocytopenic purpura
VX Du, G Os, JA Hovinga, I Dienava-Verdoold, J Wollersheim, ZM Ruggeri, R Fijnheer, PG Groot, B Laat
British Journal of Haematology 2012
Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura
F Callewaert, J Roodt, H Ulrichts, T Stohr, WJ van Rensburg, S Lamprecht, S Rossenu, S Priem, W Willems, JB Holz
Blood 2012
Endothelial cells express a unique transcriptional profile under very high wall shear stress known to induce expansive arterial remodeling
JM Dolan, FJ Sim, H Meng, J Kolega
American journal of physiology. Cell physiology 2012
von Willebrand disease biology: VON WILLEBRAND DISEASE BIOLOGY
M Blombäck, J Eikenboom, D Lane, C Denis, D Lillicrap
Haemophilia : the official journal of the World Federation of Hemophilia 2012
N-Acetylcysteine Reduces the Size and Activity of von Willebrand Factor: A Potential Therapy for Thrombotic Thrombocytopenic Purpura
Junmei Chen, Adili Reheman, Francisca Gushiken, Leticia Nolasco, Xiaoyun Fu, Joel Moake, Heyu Ni, José López
Journal of Clinical Investigation 2011
In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall
M Rybaltowski, Y Suzuki, H Mogami, I Chlebinska, T Brzoska, A Tanaka, F Banno, T Miyata, T Urano
Pflügers Archiv - European Journal of Physiology 2011
Critical Care Obstetrics
WE Scorza, A Scardella
Critical Care Obstetrics 2011
Advances in Clinical Chemistry
M Mahler
Advances in Clinical Chemistry Volume 54 2011
Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience
MJ Jang, SY Chong, IH Kim, JH Kim, CW Jung, JY Kim, JC Park, SM Lee, YK Kim, JE Lee, SS Jang, JS Kim, DY Jo, DY Zang, YY Lee, HY Yhim, D Oh
International Journal of Hematology 2011
Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies
B Plaimauer, JA Hovinga, C Juno, MJ Wolfsegger, S Skalicky, M Schmidt, L Grillberger, M Hasslacher, P Knöbl, H Ehrlich, F Scheiflinger
Journal of Thrombosis and Haemostasis 2011
Molecular cloning, in vitro expression and functional characterization of canine ADAMTS13
H Maruyama, K Ito, K Okabayashi, M Sakai, R Kano, T Watari, A Hasegawa, H Kamata
Research in Veterinary Science 2011
Modulation of the von Willebrand factor-dependent platelet adhesion through alternative proteolytic pathways
N Wohner, A Kovács, R Machovich, K Kolev
Thrombosis Research 2011
Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor
JT Crawley, R Groot, Y Xiang, BM Luken, DA Lane
Blood 2011
Henry's Clinical Diagnosis and Management by Laboratory Methods
JL Miller, AK Rao
Henry's Clinical Diagnosis and Management by Laboratory Methods 2011
von Willebrand factor self-association on platelet GpIbα under hydrodynamic shear: effect on shear-induced platelet activation
KM Dayananda, I Singh, N Mondal, S Neelamegham
Blood 2010
Assessment of endothelial dysfunction
B Freestone, S Krishnamoorthy, GY Lip
Expert Review of Cardiovascular Therapy 2010
Haemolytic uraemic syndrome associated with H1N1 influenza
A Farinha, P Carrilho, J Felgueiras, A Natario, J Assuncao, J Vinhas
NDT Plus 2010
Thrombotic thrombocytopenic purpura with decreased level of ADAMTS-13 activity and increased level of ADAMTS-13 inhibitor in an adolescent
EM Yang, DK Han, HJ Baek, MG Shin, YO Kim, H Kook, TJ Hwang
Korean Journal of Pediatrics 2010
Postgraduate Haematology
PM Mannucci, F Peyvandi, R Palla
Postgraduate Haematology 2010
Nanoporous protein matrix made of amyloid fibrils of β2-microglobulin
M Ahn, S Kang, HJ Koo, JH Lee, YS Lee, SR Paik
Biotechnology Progress 2010
Computational study of pulsatile blood flow in prototype vessel geometries of coronary segments
AK Chaniotis, L Kaiktsis, D Katritsis, E Efstathopoulos, I Pantos, V Marmarellis
Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) 2010
Disulfide Bond Reduction of Von Willebrand Factor by ADAMTS-13†
HC Yeh, Z Zhou, H Choi, S Tekeoglu, WM 3rd, C Wang, N Turner, F Scheiflinger, JL Moake, JF Dong
Journal of Thrombosis and Haemostasis 2010
Thrombotic Microangiopathies: Multimers, Metalloprotease, and Beyond
J Moake
Clinical and Translational Science 2009
Application of Fluorescence Spectroscopy to Quantify Shear-Induced Protein Conformation Change
E Themistou, I Singh, C Shang, SV Balu-Iyer, P Alexandridis, S Neelamegham
Biophysical Journal 2009
Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage
NA Turner, L Nolasco, ZM Ruggeri, JL Moake
Blood 2009
Thrombotic Thrombocytopenic Purpura: The Masquerader
A Patel, H Patel, A Patel
Southern Medical Journal 2009
Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies
J Moake
Best Practice & Research Clinical Haematology 2009
The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remission
E Groot, R Fijnheer, SA Sebastian, PG de Groot, PJ Lenting
Journal of Thrombosis and Haemostasis 2009
INHERITED BLEEDING DISORDERS IN PREGNANCY
SR Pavord, W Lester
Fetal and Maternal Medicine Review 2009
ADAMTS-13 attenuates thrombus formation on type I collagen surface and disrupted plaques under flow conditions
S Moriguchi-Goto, A Yamashita, N Tamura, K Soejima, M Takahashi, T Nakagaki, S Goto, Y Asada
Atherosclerosis 2009
Granular Assembly of α-Synuclein Leading to the Accelerated Amyloid Fibril Formation with Shear Stress
G Bhak, JH Lee, JS Hahn, SR Paik, H Lashuel
PloS one 2009
Intensive Care Medicine
JL Vincent
Intensive Care Medicine 2009
Novartis Foundation Symposia
EJ Campbell
Ciba Foundation Symposium 44 - Research and Medical Practice: Their Interaction 2008
Function of von Willebrand factor in haemostasis and thrombosis
AJ Reininger
Haemophilia 2008
Platelet Activation Due to Hemodynamic Shear Stresses: Damage Accumulation Model and Comparison to In Vitro Measurements
M Nobili, J Sheriff, U Morbiducci, A Redaelli, D Bluestein
ASAIO Journal 2008
Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions
Y Li, H Choi, Z Zhou, L Nolasco, HJ Pownall, J Voorberg, JL Moake, JF Dong
Journal of Thrombosis and Haemostasis 2008
Platelet glycoprotein Ibα gene polymorphism and massive or submassive pulmonary embolism
A Soylu, M Tokaç, T Çora, MA Düzenli, H Acar
Journal of Thrombosis and Thrombolysis 2008
Effect of adsorbed von Willebrand factor and fibrinogen on platelet interactions with synthetic materials under flow conditions
Y Wu, M Zhang, KD Hauch, TA Horbett
Journal of Biomedical Materials Research Part A 2008
Differential diagnosis of thrombotic thrombocytopenic purpura / hemolytic uremic syndrome
H Wada
Nihon Shuchu Chiryo Igakukai zasshi 2008
Platelets undergo phosphorylation of Syk at Y525/526 and Y352 in response to pathophysiological shear stress
HE Speich, S Grgurevich, TJ Kueter, AD Earhart, SM Slack, LK Jennings
American journal of physiology. Cell physiology 2008
Antihemostatic Activity of Human Granzyme B Mediated by Cleavage of von Willebrand Factor
MS Buzza, JM Dyson, H Choi, EE Gardiner, RK Andrews, D Kaiserman, CA Mitchell, MC Berndt, JF Dong, PI Bird
The Journal of biological chemistry 2008
Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura
M Manea, AC Kristoffersson, R Schneppenheim, MA Saleem, PW Mathieson, M Mörgelin, P Björk, L Holmberg, D Karpman
British Journal of Haematology 2007
Further characterization of ADAMTS-13 inactivation by thrombin
JK Lam, CK Chion, S Zanardelli, DA Lane, JT Crawley
Journal of Thrombosis and Haemostasis 2007
Shear elegance: regulation of thrombus growth by shear stress
WE Hobbs, JA Lopez
Blood 2007
Angiodysplasie digestive révélant un syndrome de Willebrand acquis associé à un myélome multiple A propos d’un cas
S Reggoug, I Errabih, N Benzzoubeir, H Krami, L Ouazzani, N Amrani, H Ouazzani
Acta Endoscopica 2007
Journey in reverse: TTP from bedside to blood bank to bench
JL Moake
Journal of Clinical Apheresis 2007
Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels
M Matsumoto, K Kawa, M Uemura, S Kato, H Ishizashi, A Isonishi, H Yagi, YD Park, Y Takeshima, Y Kosaka, H Hara, S Kai, A Kanamaru, S Fukuhara, M Hino, M Sako, A Hiraoka, H Ogawa, J Hara, Y Fujimura
Bone Marrow Transplantation 2007
TTP and ADAMTS13: When Is Testing Appropriate?
PM Mannucci, F Peyvandi
Hematology 2007
Desmopressin in inherited disorders of platelet function
A Coppola, GD Minno
Haemophilia 2007
Shear-induced unfolding triggers adhesion of von Willebrand factor fibers
SW Schneider, S Nuschele, A Wixforth, C Gorzelanny, A Alexander-Katz, RR Netz, MF Schneider
Proceedings of the National Academy of Sciences 2007
Rash and Neurological Symptoms
JK McCormick, ES Nadel, DF Brown
Journal of Emergency Medicine 2007
Thrombotic Thrombocytopenic Purpura
JL Moake
Consultative Hemostasis and Thrombosis 2007
Consultative Hemostasis and Thrombosis
VJ Marder
Consultative Hemostasis and Thrombosis 2007
Side Effects of Drugs Annual
T Vial, J Descotes, F Braun, M Behrend
Side Effects of Drugs Annual 2007
Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: A retrospective multicenter study
F Altuntas, I Aydogdu, S Kabukcu, I Kocyigit, K Cıkım, I Sarı, MA Erkut, B Eser, A Ozturk, E Kaya, M Cetin, A Keskin, A Unal
Transfusion and Apheresis Science 2007
Shear-induced Disulfide Bond Formation Regulates Adhesion Activity of von Willebrand Factor
H Choi, K Aboulfatova, HJ Pownall, R Cook, J Dong
The Journal of biological chemistry 2007
ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura
M Manea, AC Kristoffersson, HM Tsai, W Zhou, I Winqvist, G Oldaeus, R Billström, P Björk, L Holmberg, D Karpman
European Journal of Pediatrics 2006
Modulation of ADAMTS13 secretion and specific activity by a combination of common amino acid polymorphisms and a missense mutation
B Plaimauer, J Fuhrmann, G Mohr, W Wernhart, K Bruno, S Ferrari, C Konetschny, G Antoine, M Rieger, F Scheiflinger
Blood 2006
Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange*
M Darmon, E Azoulay, G Thiery, M Ciroldi, L Galicier, N Parquet, A Veyradier, JR Gall, E Oksenhendler, B Schlemmer
Critical Care Medicine 2006
Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura
Z Tao, K Anthony, Y Peng, H Choi, L Nolasco, L Rice, JL Moake, JF Dong
Journal of Thrombosis and Haemostasis 2006
New light on an old story: von Willebrand factor binding to collagen
J Chen, JA López
Journal of Thrombosis and Haemostasis 2006
The pathogenicity of von Willebrand factor in thrombotic thrombocytopenic purpura: reconsideration of treatment with cryopoor plasma
TJ Raife, KD Friedman, DM Dwyre
Transfusion 2006
Thrombotic Thrombocytopenic Purpura: aetiology, pathophysiology and treatment
RJ Murrin, JA Murray
Blood Reviews 2006
Size regulation of von Willebrand factor–mediated platelet thrombi by ADAMTS13 in flowing blood
R Donadelli, JN Orje, C Capoferri, G Remuzzi, ZM Ruggeri
Blood 2006
Platelets Treated with Ticlopidine Are Less Reactive to Unusually Large von Willebrand Factor Multimers than Are Those Treated with Aspirin under High Shear Stress
M Matsumoto, S Kawaguchi, H Ishizashi, H Yagi, J Iida, T Sakaki, Y Fujimura
Pathophysiology of Haemostasis and Thrombosis 2005
Platelet-derived VWF-cleaving metalloprotease ADAMTS-13
L Liu, H Choi, A Bernardo, AL Bergeron, L Nolasco, C Ruan, JL Moake, JF Dong
Journal of Thrombosis and Haemostasis 2005
Shear stress and the role of high molecular weight von Willebrand factor multimers in thrombus formation
JA López, J Dong
Blood Coagulation & Fibrinolysis 2005
Haemolytic uraemic syndrome is an immune-mediated disease: role of anti-CD36 antibodies
G Rock, W Clark, M Sternbach, M Kolajova, P McLaine
British Journal of Haematology 2005
Opposite changes of ADAMTS-13 and von Willebrand factor after cardiac surgery
PM Mannucci, A Parolari, MT Canciani, F Alemanni, M Camera
Journal of Thrombosis and Haemostasis 2005
Cloning, expression and functional characterization of the full-length murine ADAMTS13
K Bruno, D Volkel, B Plaimauer, G Antoine, S Pable, DG Motto, HL Lemmerhirt, F Dorner, K Zimmermann, F Scheiflinger
Journal of Thrombosis and Haemostasis 2005
Acquired thrombotic thrombocytopenic purpura as the presenting symptom of systemic lupus erythematosus. Successful treatment with plasma exchange and immunosuppression - report of two cases
M Starck, F Abedinpour, U Dendorfer, J Wagner-Czekalla, M Pachmann, JF Mann, C Nerl
European Journal of Haematology 2005
Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions
JF Dong
Journal of Thrombosis and Haemostasis 2005
Decreased Activity of Plasma ADAMTS13 May Contribute to the Development of Liver Disturbance and Multiorgan Failure in Patients with Alcoholic Hepatitis
M Uemura, T Matsuyama, M Ishikawa, M Fujimoto, H Kojima, S Sakurai, S Ishii, M Toyohara, M Yamazaki, H Yoshiji, J Yamao, M Matsumoto, H Ishizashi, Y Fujimura, H Fukui
Alcoholism: Clinical and Experimental Research 2005
Thrombotic thrombocytopenic purpura in the setting of systemic sclerosis
AM Manadan, C Harris, JA Block
Seminars in Arthritis and Rheumatism 2005
Purpura thrombotique thrombocytopénique et autres syndromes de microangiopathie thrombotique
P Coppo, JP Vernant, A Veyradier, V Frémeaux-Bacchi, JP Mira, B Guidet, E Azoulay, E Rondeau, A Bussel
EMC - Hematologie 2005
Evaluation of platelet function under high shear condition in the small-sized collagen bead column
M Kaneko, T Takafuta, O Cuyun-Lira, K Satoh, M Arai, Y Yatomi, Y Ozaki
Journal of Laboratory and Clinical Medicine 2005
Zinc and Calcium Ions Cooperatively Modulate ADAMTS13 Activity
PJ Anderson, K Kokame, JE Sadler
The Journal of biological chemistry 2005
The ADAM Family of Proteases
NM Hooper, U Lendeckel
2005
Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells
SL Haberichter, EP Merricks, SA Fahs, PA Christopherson, TC Nichols, RR Montgomery
Blood 2005
Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions
Z Tao, Y Peng, L Nolasco, S Cal, C Lopez-Otin, R Li, JL Moake, JA López, J Dong
Blood 2005
A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B
JJ Hulstein, PG de Groot, K Silence, A Veyradier, R Fijnheer, PJ Lenting
Blood 2005
Comprehensive Biochemistry
EG Erdös
Selected Topics in the History of Biochemistry Personal Recollections. VIII 2004
Proteolytic cleavage of von Willebrand factor by ADAMTS-13 prevents uninvited clumping of blood platelets
M Furlan
Journal of Thrombosis and Haemostasis 2004
Defective processing of unusually large von Willebrand factor multimers and thrombotic thrombocytopenic purpura
JL Moake
Journal of Thrombosis and Haemostasis 2004
von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura
F Peyvandi, S Ferrari, S Lavoretano, MT Canciani, PM Mannucci
British Journal of Haematology 2004
Variations among normal individuals in the cleavage of endothelial-derived ultra-large von Willebrand factor under flow
JF Dong, J Whitelock, A Bernardo, C Ball, MA Cruz
Journal of Thrombosis and Haemostasis 2004
Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS)
C Licht, L Stapenhorst, T Simon, U Budde, R Schneppenheim, B Hoppe
Kidney International 2004
The activity of the von Willebrand factor cleaving protease ADAMTS-13 in newborn infants
M Schmugge, MS Dunn, KS Amankwah, VS Blanchette, J Freedman, ML Rand
Journal of Thrombosis and Haemostasis 2004
Measurement of von Willebrand factor cleaving protease (ADAMTS-13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas
A Tripodi, V Chantarangkul, M Böhm, U Budde, JF Dong, KD Friedman, M Galbusera, JP Girma, J Moake, ME Rick, JD Studt, PL Turecek, PM Mannucci
Journal of Thrombosis and Haemostasis 2004
Regional Left Atrial Coagulation and Fibrinolytic Activities in Patients With Mitral Stenosis
A Boyaci, S Topaloglu, S Yilmaz, O Yanik, O Ozdemir, AD Demir, D Aras, H Kisacik, S Korkmaz
Japanese Heart Journal 2004
Thrombotic thrombocytopenic purpura: survival by "giving a dam"
JL Moake
Transactions of the American Clinical and Climatological Association 2004
Cleavage of von Willebrand factor by ADAMTS-13 on endothelial cells
JA López, J Dong
Seminars in Hematology 2004
Treatment of von Willebrand's Disease
AJ Wood, PM Mannucci
New England Journal of Medicine 2004
Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura
JL Moake
Seminars in Hematology 2004
A case study of thrombotic thrombocytopaenic purpura: A ‘powerful poison’
D Cox, F Coyer
Australian Critical Care 2004
Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura
T Uchida, H Wada, M Mizutani, M Iwashita, H Ishihara, T Shibano, M Suzuki, Y Matsubara, K Soejima, M Matsumoto, Y Fujimura, Y Ikeda, M Murata
Blood 2004
P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface
A Padilla, JL Moake, A Bernardo, C Ball, Y Wang, M Arya, L Nolasco, N Turner, MC Berndt, B Anvari, JA López, JF Dong
Blood 2004
Effects of inflammatory cytokines on the release and cleavage of the endothelial cell–derived ultralarge von Willebrand factor multimers under flow
A Bernardo, C Ball, L Nolasco, JF Moake, J Dong
Blood 2004
Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura
C Klaus, B Plaimauer, JD Studt, F Dorner, B Lämmle, PM Mannucci, F Scheiflinger
Blood 2004
Recent Advances in Thrombotic Thrombocytopenic Purpura
JE Sadler, JL Moake, T Miyata, JN George
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2004
Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)
JE Kaufmann, UM Vischer
Journal of Thrombosis and Haemostasis 2003
Inhibition of von Willebrand factor-GPIb/IX/V interactions as a strategy to prevent arterial thrombosis
A Bonnefoy, J Vermylen, MF Hoylaerts
Expert Review of Cardiovascular Therapy 2003
Plasma from patients with thrombotic thrombocytopenic purpura induces activation of human monocytes and polymorphonuclear neutrophils
A Alvarez-Larr��n, J Petriz, A Mart��nez, C Sanz, A Pereira
British Journal of Haematology 2003
High-Dose Plasma Infusion versus Plasma Exchange as Early Treatment of Thrombotic Thrombocytopenic Purpura/Hemolytic-Uremic Syndrome
P Coppo, A Bussel, S Charrier, C Adrie, L Galicier, E Boulanger, A Veyradier, T Leblanc, C Alberti, E Azoulay, JR Gall, B Schlemmer
Medicine 2003
Diagnosis of thrombotic thrombocytopenic purpura based on modulation by patient plasma of normal platelet adhesion under flow condition
B Shenkman, A Inbal, I Tamarin, A Lubetsky, N Savion, D Varon
British Journal of Haematology 2003
ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13
G Antoine, K Zimmermann, B Plaimauer, M Grillowitzer, JD Studt, B Lammle, F Scheiflinger
British Journal of Haematology 2003
Intravenous administration of replication-incompetent adenovirus to rhesus monkeys induces thrombocytopenia by increasing in vivo platelet clearance
N Wolins, J Lozier, TL Eggerman, E Jones, E Aguilar-Cordova, JG Vostal
British Journal of Haematology 2003
A novel flow cytometric analysis for platelet activation on immobilized von Willebrand factor or fibrillar collagen
S Kao, NA Turner, JL Moake, LV Mcintire
Journal of Thrombosis and Haemostasis 2003
Glycoprotein Ib-IX-mediated activation of integrin alphaIIbbeta3: effects of receptor clustering and von Willebrand factor adhesion
M Arya, JA Lopez, GM Romo, MA Cruz, A Kasirer-Friede, SJ Shattil, B Anvari
Journal of Thrombosis and Haemostasis 2003
Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura
M Furlan
Expert Review of Cardiovascular Therapy 2003
Pediatric septic shock and multiple organ failure
JA Carcillo
Critical Care Clinics 2003
The Relationship of von Willebrand Factor Binding to Activated Platelets from Healthy Neonates and Adults
M Schmugge, ML Rand, KW Bang, M Mody, MS Dunn, KS Amankwah, VS Blanchette, J Freedman
Pediatric Research 2003
Shear stress augments the enhanced adhesive phenotype of cells expressing the Pro33 isoform of integrin β3
KV Vijayan, TC Huang, Y Liu, A Bernardo, JF Dong, PJ Goldschmidt-Clermont, BR Alevriadou, PF Bray
FEBS Letters 2003
Endothelial function and coagulant factors in growth hormone-treated hypopituitary adults receiving desmopressin
JC Smith, HA Lane, J Lewis, S Dann, J Goodfellow, P Collins, LM Evans, MF Scanlon, JS Davies
The Journal of clinical endocrinology and metabolism 2003
Hemostasia, angiogénesis y cáncer: papel del factor von Willebrand
I Gil-Bazo, J García-Foncillas, JA Fernández
Revista Clínica Española 2003
Platelets and von Willebrand factor
M Schmugge, ML Rand, J Freedman
Transfusion and Apheresis Science 2003
ADAMTS-13 Metalloprotease Interacts with the Endothelial Cell-derived Ultra-large von Willebrand Factor
J Dong, JL Moake, A Bernardo, K Fujikawa, C Ball, L Nolasco, JA López, MA Cruz
The Journal of biological chemistry 2003
Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension
H Shankaran, P Alexandridis, S Neelamegham
Blood 2003
Activation of pp125FAK by type 2B recombinant von Willebrand factor binding to platelet GPIb at a high shear rate occurs independently of αIIbβ3 engagement
M Mekrache, C Bachelot-Loza, N Ajzenberg, A Saci, P Legendre, D Baruch
Blood 2003
Changes in von Willebrand factor–cleaving protease (ADAMTS13) activity after infusion of desmopressin
RA Reiter, P Knöbl, K Varadi, PL Turecek
Blood 2003
Thrombotic Thrombocytopenic Purpura Associated with Bone Marrow Metastasis and Secondary Myelofibrosis in Cancer
JC Chang, T Naqvi
The oncologist 2003
Cytoplasmic Truncation of Glycoprotein Ibα Weakens Its Interaction with von Willebrand Factor and Impairs Cell Adhesion
AJ Schade, M Arya, S Gao, R Diz-Küçükkaya, B Anvari, LV McIntire, JA López, J Dong
Biochemistry 2003
Nonneutralizing IgM and IgG antibodies to von Willebrand factor–cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura
F Scheiflinger, P Knöbl, B Trattner, B Plaimauer, G Mohr, M Dockal, F Dorner, M Rieger
Blood 2003
von Willebrand Factor—Cleaving Protease and Upshaw-Schulman Syndrome
Y Fujimura, M Matsumoto, H Yagi, A Yoshioka, T Matsui, K Titani
International Journal of Hematology 2002
Control of von Willebrand factor multimer size and implications for disease
J Pimanda, P Hogg
Blood Reviews 2002
Shear-induced platelet aggregation increases in patients with proximal and severe coronary artery stenosis
K Kawano, H Yoshino, N Aoki, H Udagawa, A Watanuki, Y Hioki, Y Hasumura, T Yasumura, M Homori, M Murata, Y Ikeda, K Ishikawa
Clinical Cardiology 2002
Measurement of the binding forces between von Willebrand factor and variants of platelet glycoprotein Ib? using optical tweezers
M Arya, JA L�pez, GM Romo, JF Dong, LV McIntire, JL Moake, B Anvari
Lasers in Surgery and Medicine 2002
THROMBOTICTHROMBOCYTOPENICPURPURA: The Systemic Clumping “Plague”
JL Moake
Annual Review of Medicine 2002
Thrombotic Microangiopathies
JL Moake
New England Journal of Medicine 2002
Ultralarge von Willebrand factor multimers and normal ADAMTS13 activity in the umbilical cord blood
HM Tsai, R Sarode, KA Downes
Thrombosis Research 2002
Deficiency of von Willebrand factor-cleaving protease activity in the plasma of malignant patients
BH Koo, D Oh, SY Chung, NK Kim, S Park, Y Jang, KH Chung
Thrombosis Research 2002
Local blood serotonin and soluble P-selectin levels during percutaneous transluminal balloon angioplasty and primary stenting of the iliac artery
T Onohara, K Komori, H Inoguchi, S Yamamura
Surgery 2002
Juvenile dermatomyositis: immunogenetics, pathophysiology, and disease expression
LM Pachman
Rheumatic Disease Clinics of North America 2002
Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation
YD Park, A Yoshioka, K Kawa, H Ishizashi, H Yagi, Y Yamamoto, M Matsumoto, Y Fujimura
Bone Marrow Transplantation 2002
The von Willebrand factor–reducing activity of thrombospondin-1 is located in the calcium-binding/C-terminal sequence and requires a free thiol at position 974
JE Pimanda, DS Annis, M Raftery, DF Mosher, CN Chesterman, PJ Hogg
Blood 2002
Shear-dependent morphology of von Willebrand factor bound to immobilized collagen
L Novák, H Deckmyn, S Damjanovich, J Hársfalvi
Blood 2002
Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers
M Arya, B Anvari, GM Romo, MA Cruz, JF Dong, LV McIntire, JL Moake, JA López
Blood 2002
ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions
J Dong, JL Moake, L Nolasco, A Bernardo, W Arceneaux, CN Shrimpton, AJ Schade, LV McIntire, K Fujikawa, JA López
Blood 2002
von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome
G Remuzzi, M Galbusera, M Noris, MT Canciani, E Daina, E Bresin, S Contaretti, J Caprioli, S Gamba, P Ruggenenti, N Perico, PM Mannucci
Blood 2002
Thrombotic Thrombocytopenic Purpura and the Hemolytic Uremic Syndrome
JL Moake
Archives of pathology & laboratory medicine 2002
Prothrombotic response to coronary angioplasty in patients with unstable angina and raised C-reactive protein
Alessandro Sciahbasi, Felicita Andreotti, Raimondo De Cristofaro, Dionigi Fischetti, Antonio Maria Leone, Giovanni Schiavoni, Attilio Maseri, Raffaele Landolfi
Journal of Thrombosis and Thrombolysis 2002
Japanese Journal of Thrombosis and Hemostasis
M OKUDAIRA, H ASAKURA, Y SANO, Y SUGA, M YAMAZAKI, K AOSHIMA, E MORISHITA, M SAITO, Y ONTACHI, T MIZUTANI, M KATO, T ITO, K MIYAMOTO, S NAKAO
Japanese Journal of Thrombosis and Hemostasis 2001
Control of Von Willebrand Factor Multimer Size by Thrombospondin-1
L Xie, CN Chesterman, PJ Hogg
Journal of Experimental Medicine 2001
Deficient Activity of von Willebrand Factor-Cleaving Protease in Patients With Upshaw-Schulman Syndrome
Y Sasahara, S Kumaki, Y Ohashi, M Minegishi, H Kano, F Bessho, S Tsuchiya
International Journal of Hematology 2001
ticlopidine-Associated Thrombotic Thrombocytopenic Purpura With an IgG-Type Inhibitor to von Willebrand Factor-Cleaving Protease Activity
Y Sugio, T Okamura, K Shimoda, M Matsumoto, H Yagi, H Ishizashi, Y Niho, S Inaba, Y Fujimura
International Journal of Hematology 2001
Function and Clinical Significance of Platelet-Derived Microparticles
S Nomura
International Journal of Hematology 2001
Upshaw-Schulman Syndrome Revisited: A Concept of Congenital Thrombotic Thrombocytopenic Purpura
S Kinoshita, A Yoshioka, YD Park, H Ishizashi, M Konno, M Funato, T Matsui, K Titani, H Yagi, M Matsumoto, Y Fujimura
International Journal of Hematology 2001
Mechanisms of platelet aggregation
B Savage, M Cattaneo, ZM Ruggeri
Current Opinion in Hematology 2001
Clinical application of a rapid method using agarose gel electrophoresis and Western blotting to evaluate von Willebrand factor protease activity
DM Krizek, ME Rick
Electrophoresis 2001
Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage
M Fukuchi, J Watanabe, K Kumagai, Y Katori, S Baba, K Fukuda, T Yagi, A Iguchi, H Yokoyama, M Miura, Y Kagaya, S Sato, K Tabayashi, K Shirato
Journal of the American College of Cardiology 2001
Abnormal von Willebrand Factor in Bleeding Angiodysplasias of the Digestive Tract
A Veyradier, A Balian, M Wolf, V Giraud, S Montembault, B Obert, I Dagher, JC Chaput, D Meyer, S Naveau
Gastroenterology 2001
Incidence of allergic reactions with fresh frozen plasma or cryo-supernatant plasma in the treatment of thrombotic thrombocytopenic purpura
JC Reutter, KF Sanders, ME Brecher, HG Jones, N Bandarenko
Journal of Clinical Apheresis 2001
NEW ASPECTS IN THE PATHOGENESIS AND TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA AND HEMOLYTIC UREMIC SYNDROME
T Raife, R Montgomery
Reviews in Clinical and Experimental Hematology 2001
Extracorporeal Plasma Treatment in Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome: A Review
T Bosch, T Wendler
Therapeutic Apheresis and Dialysis 2001
Plasma of patients with Upshaw-Schulman syndrome, a congenital deficiency of von Willebrand factor-cleaving protease activity, enhances the aggregation of normal platelets under high shear stress
H Yagi, M Konno, S Kinoshita, M Matsumoto, H Ishizashi, T Matsui, K Titani, Y Fujimura
British Journal of Haematology 2001
Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease
M Furlan, B Lämmle
Best Practice & Research Clinical Haematology 2001
Control of von Willebrand factor multimer size by thrombospondin-1
L Xie, CN Chesterman, PJ Hogg
Journal of Experimental Medicine 2001
Glycoprotein Ib/IX/V Binding to the Membrane Skeleton Maintains Shear-Induced Platelet Aggregation
N Christodoulides, S Feng, JC Reséndiz, MC Berndt, MH Kroll
Thrombosis Research 2001
Standardized ultrasound as a new method to induce platelet aggregation
C Otto, M Baumann, T Schreiner, G Bartsch, H Borberg, P Schwandt, H Schmid-Schönbein
European Journal of Ultrasound 2001
Report on the workshop: Von Willebrand factor and thrombotic thrombocytopenic purpura
JL Moake, JE Sadler, P Mannucci, P Ganguly
American Journal of Hematology 2001
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor
PM Mannucci, MT Canciani, I Forza, F Lussana, A Lattuada, E Rossi
Blood 2001
Microvascular thrombosis in pediatric multiple organ failure: Is it a therapeutic target?:
T Nguyen, M Hall, Y Han, M Fiedor, A Hasset, I Lopez-Plaza, S Watson, L Lum, JA Carcillo
Pediatric Critical Care Medicine 2001
Drug-Induced Thrombotic Microangiopathy: Incidence, Prevention and Management
R Pisoni, P Ruggenenti, G Remuzzi
Drug Safety 2001
Blockade of adenosine diphosphate receptors P2Y12 and P2Y1 is required to inhibit platelet aggregation in whole blood under flow
NA Turner, JL Moake, LV McIntire
Blood 2001
Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions
JF Dong, MC Berndt, A Schade, LV McIntire, RK Andrews, JA López
Blood 2001
Platelets: An Update on Diagnosis and Management of Thrombocytopenic Disorders
KR McCrae, JB Bussel, PM Mannucci, G Remuzzi, DB Cines
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2001
Partial amino acid sequence of purified von Willebrand factor–cleaving protease
HE Gerritsen, R Robles, B Lämmle, M Furlan
Blood 2001
Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders
JC Moore, CP Hayward, TE Warkentin, JG Kelton
Blood 2001
Specific von Willebrand factor–cleaving protease in thrombotic microangiopathies: a study of 111 cases
A Veyradier, B Obert, A Houllier, D Meyer, JP Girma
Blood 2001
Modulation of platelet aggregation after percutaneous transluminal angioplasty of the iliac artery for atherosclerosis obliterans
T Onohara, K Komori, S Yamamura, Y Fujinaga, K Sugimachi
Surgery 2000
von Willebrand factor and thrombotic thrombocytopenic purpura
TJ Raife, RR Montgomery
Current Opinion in Hematology 2000
Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation
S Nomura, T Nakamura, J Cone, NN Tandon, J Kambayashi
Cytometry 2000
In vitro bleeding time test can diagnose thrombotic thrombocytopenia purpura and can possibly monitor therapeutic plasma apheresis
DB Brubaker, CK Brubaker, L Chandler, J Smith, RO Gilcher
Journal of Clinical Apheresis 2000
Acute thrombotic thrombocytopenic purpura following abdominal surgeries: A report of three cases
JC Chang, M El-Tarabily, S Gupta
Journal of Clinical Apheresis 2000
Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years
Mannucci
Haemophilia 2000
Centrosome-directed translocation of Weibel-Palade bodies is rapidly induced by thrombin, calyculin A, or cytochalasin B in human aortic endothelial cells
TM Vinogradova, VE Roudnik, VB Bystrevskaya, VN Smirnov
Cell Motility and the Cytoskeleton 2000
Platelet-Derived Microparticles in Patients with Arteriosclerosis Obliterans
S Nomura, A Imamura, M Okuno, Y Kamiyama, Y Fujimura, Y Ikeda, S Fukuhara
Thrombosis Research 2000
A novel interpretation of the role of von Willebrand factor in thrombotic microangiopathies based on platelet adhesion studies at high shear rate flow
M Galbusera, A Remuzzi, A Benigni, C Rossi, G Remuzzi
American journal of kidney diseases : the official journal of the National Kidney Foundation 2000
Thrombin receptor activating peptide (SFLLRN) potentiates shear-induced platelet microvesiculation
TW Chow, JD Hellums, P Thiagarajan
Journal of Laboratory and Clinical Medicine 2000
Criterios diagnósticos y diagnóstico diferencial de la púrpura trombótica trombocitopénica
AP Vigo, CZ de Pedro, MH Jodra
Revista Clínica Española 2000
Signaling across the Platelet Adhesion Receptor Glycoprotein Ib-IX Induces α IIb β 3 Activation Both in Platelets and a Transfected Chinese Hamster Ovary Cell System
Y Zaffran, SC Meyer, E Negrescu, KB Reddy, JE Fox
The Journal of biological chemistry 2000
Current understanding of the pathophysiology of thrombotic thrombocytopenic purpura
SL Allford
Journal of clinical pathology 2000
Haemolytic‐uraemic syndrome and thrombotic thrombocytopenic purpura—new insights into underlying biochemical mechanisms
M Furlan, B Lämmle
Nephrology Dialysis Transplantation 2000
Effects of Abciximab, Ticlopidine, and Combined Abciximab/Ticlopidine Therapy on Platelet and Leukocyte Function in Patients Undergoing Coronary Angioplasty
BJ Fredrickson, NA Turner, NS Kleiman, N Graziadei, K Maresh, MA Mascelli, MB Effron, LV McIntire
Circulation 2000
Proteolysis of von Willebrand Factor and Shear Stress–Induced Platelet Aggregation in Patients With Aortic Valve Stenosis
FI Pareti, A Lattuada, C Bressi, M Zanobini, A Sala, A Steffan, ZM Ruggeri
Circulation 2000
Platelet Thrombus Formation on Collagen at High Shear Rates Is Mediated by von Willebrand Factor–Glycoprotein Ib Interaction and Inhibited by von Willebrand Factor–Glycoprotein IIb/IIIa Interaction
YP Wu, T Vink, M Schiphorst, GH van Zanten, MJ IJsseldijk, PG de Groot, JJ Sixma
Arteriosclerosis, thrombosis, and vascular biology 2000
Cytoskeletal regulation of the platelet glycoprotein Ib/V/IX–von Willebrand factor interaction
N Mistry, SL Cranmer, Y Yuan, P Mangin, SM Dopheide, I Harper, S Giuliano, DE Dunstan, F Lanza, HH Salem, SP Jackson
Blood 2000
Effect of recombinant von Willebrand factor reproducing type 2B or type 2M mutations on shear-induced platelet aggregation
N Ajzenberg, AS Ribba, G Rastegar-Lari, D Meyer, D Baruch
Blood 2000
Characterization of von Willebrand factor in primary pulmonary hypertension
MT Collados, J Sandoval, S López, FA Massó, A Páez, JR Borbolla, LF Montaño
Heart and Vessels 1999
The Effect of Polyclonal Antibody against Fibronectin on von Willebrand Factor Multimeric Size
AC Kempfer, CE Farı́as, GA Carballo, MR Silaf, MA Lazzari
Thrombosis Research 1999
Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels
L Albornoz, D Alvarez, JC Otaso, A Gadano, J Salviú, S Gerona, P Sorroche, A Villamil, R Mastai
Journal of Hepatology 1999
Current Clinical Practice: Current Management of Thrombotic Thrombocytopenic Purpura
JJ Hong, HC Kwaan
Hematology 1999
AJvW-2, an Anti-vWF Monoclonal Antibody, Inhibits Enhanced Platelet Aggregation Induced by High Shear Stress in Platelet-Rich Plasma From Patients With Acute Coronary Syndromes
K Eto, T Isshiki, H Yamamoto, S Takeshita, M Ochiai, N Yokoyama, R Yoshimoto, Y Ikeda, T Sato
Arteriosclerosis, thrombosis, and vascular biology 1999
Increased Fragmentation of von Willebrand Factor, Due to Abnormal Cleavage of the Subunit, Parallels Disease Activity in Recurrent Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura and Discloses Predisposition in Families
M Galbusera, M Noris, C Rossi, S Orisio, J Caprioli, ZM Ruggeri, B Amadei, P Ruggenenti, B Vasile, G Casari, G Remuzzi
Blood 1999
Unrecognized Pattern of von Willebrand Factor Abnormalities in Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura
M Galbusera, A Benigni, S Paris, P Ruggenenti, C Zoja, C Rossi, G Remuzzi
Journal of the American Society of Nephrology : JASN 1999
Biomechanics of cell interactions in shear fields
K Konstantopoulos, S Kukreti, LV McIntire
Advanced Drug Delivery Reviews 1998
Increased von Willebrand factor (vWf) binding to platelets associated with impaired vWf breakdown in thrombotic thrombocytopenic purpura
JL Moake, TW Chow
Journal of Clinical Apheresis 1998
Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura
TW Chow, NA Turner, M Chintagumpala, PD McPherson, LH Nolasco, L Rice, JD Hellums, JL Moake
American Journal of Hematology 1998
Thrombotic Thrombocytopenic Purpura: Understanding a Disease No Longer Rare
JL Moake, TW Chow
The American Journal of the Medical Sciences 1998
Moschcowitz, Multimers, and Metalloprotease
JL Moake
New England Journal of Medicine 1998
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
M Furlan, R Robles, M Galbusera, G Remuzzi, PA Kyrle, B Brenner, M Krause, I Scharrer, V Aumann, U Mittler, M Solenthaler, B Lämmle
New England Journal of Medicine 1998
Platelet aggregation in flow: Differential roles for adhesive receptors and ligands
MM Frojmovic
American Heart Journal 1998
16 Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura
M Furlan, B Lämmle
Baillière's Clinical Haematology 1998
Distinct sequences of the glycoprotein Ib-binding domain of von Willebrand factor involved in shear induced platelet aggregation
N Ajzenberg, H Depraetere, C Lacombe, H Deckmyn, D Baruch
Platelets 1998
von Willebrand Factor: A Marker of Endothelial Damage?
PM Mannucci
Arteriosclerosis, thrombosis, and vascular biology 1998
Activation of Platelets in Platelet-Rich Plasma by Rotablation Is Speed-Dependent and Can Be Inhibited by Abciximab (c7E3 Fab; ReoPro)
MS Williams, BS Coller, HJ Väänänen, LE Scudder, SK Sharma, JD Marmur
Circulation 1998
Purine Nucleotides Induce Regulated Secretion of von Willebrand Factor: Involvement of Cytosolic Ca2+ and Cyclic Adenosine Monophosphate–Dependent Signaling in Endothelial Exocytosis
UM Vischer, CB Wollheim
Blood 1998
Acquired Deficiency of von Willebrand Factor-Cleaving Protease in a Patient With Thrombotic Thrombocytopenic Purpura
M Furlan, R Robles, M Solenthaler, B Lämmle
Blood 1998
Platelet Aggregation Induced by a Monoclonal Antibody to the A1 Domain of von Willebrand Factor
H Depraetere, N Ajzenberg, JP Girma, C Lacombe, D Meyer, H Deckmyn, D Baruch
Blood 1998
Shear-Dependent Rolling on von Willebrand Factor of Mammalian Cells Expressing the Platelet Glycoprotein Ib-IX-V Complex
BJ Fredrickson, JF Dong, LV McIntire, JA López
Blood 1998
Von Willebrand Factor-Dependent Shear-Induced Platelet Aggregation: Basic Mechanisms and Clinical Implications
Y Ikeda, M Murata, S Goto
Annals of the New York Academy of Sciences 1997
Calpain activation in shear-induced platelet aggregation
K Fujitani, J Kambayashi, H Ariyoshi, M Sakon, S Imajoh-Ohmi, T Nakamura, M Monden
Journal of Cellular Biochemistry 1997
Antithrombotic, procoagulant, and fibrinolytic mechanisms in cerebral circulation: implications for brain injury and protection
BV Zlokovic
Neurosurgical FOCUS 1997
Review of clinical experience of desmopressin in patients with congenital and acquired bleeding disorders
M Cattaneo
European Journal of Anaesthesiology 1997
THROMBOCYTOPENIA IN PREGNANCY
WR Bell, TS Kickler
Rheumatic Disease Clinics of North America 1997
NEW FAMILIES WITH VON WILLEBRAND DISEASE TYPE 2M (VICENZA)
B Zieger, U Budde, U Jessat, R Zimmerman, M Simon, R Kätzel, AH Sutor
Thrombosis Research 1997
BINDING OF THE VON WILLEBRAND FACTOR A1 DOMAIN TO HISTONE
CM Ward, TJ Tetaz, RK Andrews, MC Berndt
Thrombosis Research 1997
Effects of fluid shear stress on atherogenesis and hemostasis
J Ruef, C Bode, MS Runge
Fibrinolysis and Proteolysis 1997
Textbook of Coronary Thrombosis and Thrombolysis
RC Becker
1997
Tyrosine Phosphorylation and p72syk Activation by an Anti-Glycoprotein Ib Monoclonal Antibody
M Yanabu, Y Ozaki, S Nomura, T Miyake, Y Miyazaki, H Kagawa, Y Yamanaka, N Asazuma, K Satoh, S Kume, Y Komiyama, S Fukuhara
Blood 1997
Deficient Activity of von Willebrand Factor–Cleaving Protease in Chronic Relapsing Thrombotic Thrombocytopenic Purpura
M Furlan, R Robles, M Solenthaler, M Wassmer, P Sandoz, B Lämmle
Blood 1997
Desmopressin (DDAVP) in the Treatment of Bleeding Disorders: The First 20 Years
PM Mannucci
Blood 1997
Malignant vascular disease of the kidney: Nature of the lesions, mediators of disease progression, and the case for bilateral nephrectomy
P Ruggenenti, G Remuzzi
American Journal of Kidney Diseases 1996
ROLE OF ENDOTHELIUM IN THROMBOSIS AND HEMOSTASIS
KK M.D, PT M.D
Annual Review of Medicine 1996
Familial Infantile Thrombotic Thrombocytopenic Purpura
D Daghistani, JJ Jimenez, JL Moake, MR Ledford, AA Yunis
Journal of Pediatric Hematology/Oncology 1996
Abnormally large von Willebrand factor multimers in Henoch-Schönlein purpura
A Casonato, E Pontara, A Bertomoro, E Ossi, M Vincenti, A Girolami, A Borsatti, G Bertaglia
American Journal of Hematology 1996
Apheresis in grade 4 bone marrow transplant associated thrombotic microangiopathy: A case series
A Dua, ZR Zeigler, RK Shadduck, R Nath, DF Andrews, M Agha
Journal of Clinical Apheresis 1996
Role of Platelets in Restenosis After Percutaneous Coronary Revascularization
HL Breton, EF Plow, EJ Topol
Journal of the American College of Cardiology 1996
Increased platelet retention in familial recurrent thrombotic thrombocytopenic purpura
D Karpman, L Holmberg, L Jirgård, S Lethagen
Kidney International 1996
Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors
R Sreedhara, I Itagaki, RM Hakim
American Journal of Kidney Diseases 1996
THROMBOTIC MICROANGIOPATHIES ASSOCIATED WITH DRUGS AND BONE MARROW TRANSPLANTATION
JL Moake, JJ Byrnes
Hematology/Oncology Clinics of North America 1996
Immunocytochemical Aspects of Platelet Membrane Glycoproteins and Adhesive Proteins During Activation
H Suzuki, H Yamazaki, K Tanoue
Progress in Histochemistry and Cytochemistry 1996
Platelet Adhesion to Multimeric and Dimeric von Willebrand Factor and to Collagen Type III Preincubated With von Willebrand Factor
YP Wu, HH van Breugel, H Lankhof, RJ Wise, RI Handin, PG de Groot, JJ Sixma
Arteriosclerosis, thrombosis, and vascular biology 1996
The Thrombocytopenic Purpuras: Recognition and Management
S Gillis
Drugs 1996
Direct demonstration of radiolabeled von willebrand factor binding to platelet glycoprotein Ib and IIb-IIIa in the presence of shear stress
JK McCrary, LH Nolasco, JD Hellums, MH Kroll, NA Turner, JL Moake
Annals of Biomedical Engineering 1995
Differential Thrombogenicity of Artery and Vein: the Role of von Willebrand Factor
J Cho, K Ouriel
Annals of Vascular Surgery 1995
Coagulation activity is increased in the left atrium of patients with mitral stenosis
K Yamamoto, U Ikeda, Y Seino, H Mito, H Fujikawa, H Sekiguchi, K Shimada
Journal of the American College of Cardiology 1995
Defective platelet aggregation in uremia is transiently worsened by hemodialysis
R Sreedhara, I Itagaki, B Lynn, RM Hakim
American Journal of Kidney Diseases 1995
α1-antitrypsin therapy in a case of thrombotic thrombocytopenic purpura
M Galbusera, P Ruggenenti, M Noris, A Benigni, G Remuzzi, P Ruggenenti, G Remuzzi, M Burnouf-Radosevich, PM Mannucci
The Lancet 1995
Flavocetin-A and -B, two high molecular mass glycoprotein Ib binding proteins with high affinity purified fromTrimeresurus flavoviridis venom, inhibit platelet aggregation at high shear stress
Y Taniuchi, T Kawasaki, Y Fujimura, M Suzuki, K Titani, Y Sakai, S Kaku, N Hisamichi, N Satoh, T Takenaka, M Handa, Y Sawai
Biochimica et Biophysica Acta (BBA) - General Subjects 1995
Cerebrovascular Diseases
K Shen, RH Chavez-Chavez, AK Loo, BW Zweifach, J Barroso-Aranda, GW Schmid-Schönbein
Cerebrovascular Diseases 1995
Shear-Induced Platelet Aggregation Is Inhibited by In Vivo Infusion of an Anti–Glycoprotein IIb/IIIa Antibody Fragment, c7E3 Fab, in Patients Undergoing Coronary Angioplasty
K Konstantopoulos, SG Kamat, AI Schafer, EI Bañez, R Jordan, NS Kleiman, JD Hellums
Circulation 1995
Thrombotic Thrombocytopenia Induced in Dogs and Pigs: The Role of Plasma and Platelet vWF in Animal Models of Thrombotic Thrombocytopenic Purpura
WE Sanders, RL Reddick, TC Nichols, KM Brinkhous, MS Read
Arteriosclerosis, thrombosis, and vascular biology 1995
The role of platelet von Willebrand factor in platelet adhesion and thrombus formation: a study of 34 patients with various subtypes of type I von Willebrand disease
E Fressinaud, AB Federici, G Castaman, C Rothschild, F Rodeghiero, HR Baumgartner, PM Mannucci, D Meyer
British Journal of Haematology 1994
Platelet size distribution measurements as indicators of shear stress-induced platelet aggregation
SM Slack, LK Jennings, VT Turitto
Annals of Biomedical Engineering 1994
1993 Whitaker lecture: Biorheology in thrombosis research
JD Hellums
Annals of Biomedical Engineering 1994
Platelet activation and arterial thrombosis
KK Wu, M Phillips, D D'Souza, JD Hellums
The Lancet 1994
Role of ADP in platelet aggregation at high shear: studies in a patient with congenital defect of platelet responses to ADP
M Cattaneo, ML Zighetti, R Lombardi, P Mannuccio
British Journal of Haematology 1994
Markers of disease activity in systemic sclerosis
M Matucci-Cerinic, A Pignone, M Biagini, T Lotti
Clinics in Dermatology 1994
Haemolytic-uraemic syndrome: basic science
JL Moake
The Lancet 1994
High shearing forces in blood: Haemostasis, thrombosis and atherogenesis
JR O'Brien
Thrombosis Research 1994
Shear-induced platelet aggregation in cerebral ischemia
S Uchiyama, M Yamazaki, S Maruyama, M Handa, Y Ikeda, M Fukuyama, I Itagaki
Stroke; a journal of cerebral circulation 1994
Abnormalities of von willebrand factor multimers in drug-associated thrombotic microangiopathies
D Charba, JL Moake, MA Harris, JP Hester
American Journal of Hematology 1993
Endothelium-derived Relaxing Factor Inhibits Shear Stress-induced Platelet Aggregation
W Durante, AI Schafer, JK Hrbolich, RA Claure, ME Mendelsohn, MH Kroll
Platelets 1993
Desmopressin and hemostasis
JL David
Regulatory Peptides 1993
Physical Forces and the Mamilian Cell
LV McIntire, S Rajagopalan
Physical Forces and the Mamilian Cell 1993
Desmopressin in Bleeding Disorders
G Mariani, PM Mannucci, M Cattaneo
1993
Protein kinase C is activated in platelets subjected to pathological shear stress
MH Kroll, JD Hellums, Z Guo, W Durante, K Razdan, JK Hrbolich, AI Schafer
The Journal of biological chemistry 1993
A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF all
K Peerlinck, JC Eikenboom, HK Ploos, V Amstel, W Sangtawesin, J Arnout, PH Reitsma, J Vermylen, E Brieut
British Journal of Haematology 1992
Unique expression of von Willebrand factor by type IIA von Willebrand's disease endothelial cells
B Wilbourn, P Harrison, A Lawrie, F LeRoy, M Rowley, D Bevan, A Inbal, G Savidge
British Journal of Haematology 1992
Electrophoretic and functional characteristics of the von Willebrand factor in human fetal plasma
C Mazurier, F Daffos, F Forestier
British Journal of Haematology 1992
Sustained correction of the bleeding time in an afibrinogenaemic patient after infusion of fresh frozen plasma
M Cattaneo, D Bettega, R Lombardi, A Lecchi, PM Mannucci
British Journal of Haematology 1992
Pulsed laser and thermal ablation of atherosclerotic plaque: Morphometrically defined surface thrombogenicity in studies using an annular perfusion chamber
JB Lawrence, LG Prevosti, WS Kramer, PD Smith, RF Bonner, DY Lu, MB Leon
Journal of the American College of Cardiology 1992
A monomeric von Willebrand factor fragment, Leu-504--Lys-728, inhibits von Willebrand factor interaction with glycoprotein Ib-IX [corrected]
HR Gralnick, S Williams, L McKeown, W Kramer, H Krutzsch, M Gorecki, A Pinet, LI Garfinkel
Proceedings of the National Academy of Sciences 1992
Calcium/calmodulin transduces thrombin-stimulated secretion: studies in intact and minimally permeabilized human umbilical vein endothelial cells
KA Birch, JS Pober, GB Zavoico, AR Means, BM Ewenstein
The Journal of Cell Biology 1992
Thrombotic thrombocytopenic purpura associated with the acquired immune deficiency syndrome
A Kumar, J Wang, D Sutton, EJ Bow
The Canadian Journal of Infectious Diseases 1992
von Willebrand factor (vWF) abnormalities in thrombotic thrombocytopenic purpura (TTP) and the hemolytic uremic syndrome (HUS)
JL Moake
Transfusion Science 1992
Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission
MM Chintagumpala, RL Hurwitz, JL Moake, DH Mahoney, CP Steuber
The Journal of Pediatrics 1992
Epinephrine augments von Willebrand factor-dependent shear-induced platelet aggregation
S Goto, Y Ikeda, M Murata, M Handa, E Takahashi, A Yoshioka, Y Fujimura, M Fukuyama, S Handa, S Ogawa
Circulation 1992
International Yearbook of Nephrology 1993
VE Andreucci, LG Fine
1992
Advances in Cardiovascular Engineering
NH Hwang, VT Turitto, MR Yen
1992
Diagnostische Hämatologie
H Huber, H Löffler, D Pastner
1992
The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress
Y Ikeda, M Handa, K Kawano, T Kamata, M Murata, Y Araki, H Anbo, Y Kawai, K Watanabe, I Itagaki
Journal of Clinical Investigation 1991
von Willebrand factor binding to platelet GpIb initiates signals for platelet activation
MH Kroll, TS Harris, JL Moake, RI Handin, AI Schafer
Journal of Clinical Investigation 1991
von Willebrand Factor and Platelet Function
HJ Weiss
Annals of the New York Academy of Sciences 1991
Thrombotic microangiopathies
P Ruggenenti, G Remuzzi
Critical Reviews in Oncology/Hematology 1991
von Willebrand Factor and Platelet Functiona
HJ Weiss
Annals of the New York Academy of Sciences 1991
Correlation of circulating von Willebrand factor levels with cardiovascular hemodynamics
WF Penny, M Weinstein, EW Salzman, JA Ware
Circulation 1991
Cell-Cell Interactions in the Release of Inflammatory Mediators
PY Wong, CN Serhan
1991
Differential localization of von Willebrand factor, fibronectin and 13-HODE in human endothelial cell cultures
J Aznar-Salatti, E Bastida, MR Buchanan, R Castillo, A Ordinas, G Escolar
Histochemistry 1990
Von Willebrand Factor in Thrombotic Thrombocytopenic Purpura and the Hemolytic-Uremic Syndrome
JL Moake, PD McPherson
Transfusion Medicine Reviews 1990
Aurintricarboxylic acid in a canine model of coronary artery thrombosis
J Strony, M Phillips, D Brands, J Moake, B Adelman
Circulation 1990
Synergistic inhibition of platelet aggregation by fibrinogen-related peptides
B Adelman, C Gennings, J Strony, E Hanners
Circulation research 1990
Encyclopedic Reference of Vascular Biology & Pathology
A Bikfalvi
1990
New Trends in Haemostasis
J Harenberg, DL Heene, G Stehle, G Schettler
1990
Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate
HJ Weiss, J Hawiger, ZM Ruggeri, VT Turitto, P Thiagarajan, T Hoffmann
Journal of Clinical Investigation 1989
Coagulation studies in thrombotic thrombocytopenic purpura, with special reference to von willebrand factor and protein S
H Takahashi, W Tatewaki, T Nakamura, M Hanano, K Wada, A Shibata
American Journal of Hematology 1989
Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura
MJ Weinstein, R Blanchard, JL Moake, EV and, K MOISE
British Journal of Haematology 1989
Adenosine diphosphate-induced aggregation of human platelets in flow through tubes. II. Effect of shear rate, donor sex, and ADP concentration
DN Bell, S Spain, HL Goldsmith
Biophysical Journal 1989
Mathematical analysis of mural thrombogenesis. Concentration profiles of platelet-activating agents and effects of viscous shear flow
BJ Folie, LV McIntire
Biophysical Journal 1989
Glycocalicin binding to von Willebrand factor adsorbed onto collagen-coated or polystyrene surfaces
A Inbal, J Loscalzo
Thrombosis Research 1989
5 Molecular cloning, expression and assembly of multimeric von Willebrand factor
H Pannekoek, J Voorberg
Baillière's Clinical Haematology 1989
A Trial of Desmopressin (1-Desamino-8-D-Arginine Vasopressin) to Reduce Blood Loss in Uncomplicated Cardiac Surgery
T Hackmann, RD Gascoyne, SC Naiman, GH Growe, LD Burchill, WR Jamieson, SB Sheps, MT Schechter, GE Townsend
New England Journal of Medicine 1989
Thrombosis following desmopressin for uremic bleeding
JJ Byrnes, A Larcada, JL Moake
American Journal of Hematology 1988
Importance of fibrinogen and platelet membrane glycoprotein IIb/IIIa in shear-induced platelet aggregation
Y Ikeda, M Murata, Y Araki, K Watanabe, Y Ando, I Itagaki, Y Mori, M Ichitani, K Sakai
Thrombosis Research 1988
Proteolytic cleavage of the precursor of von Willebrand factor is not essential for multimer formation
CL Verweij, M Hart, H Pannekoek
The Journal of biological chemistry 1988
Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow
TM Wick, JL Moake, MM Udden, SG Eskin, DA Sears, LV McIntire
Journal of Clinical Investigation 1987
Platelet Function
AJ Marcus
New England Journal of Medicine 1969
Anticoagulation management in mechanical circulatory support
Sirtaz Adatya, Mosi K. Bennett
Journal of Thoracic Disease
Microfluidic Studies of Polymer Adsorption in Flow
A Salari, E Kumacheva
Macromolecular Chemistry and Physics 2016
Diagnostic and therapeutic guidelines of thrombotic microangiopathies of the Spanish Apheresis Group
E Contreras, J la Rubia, J Río-Garma, M Díaz-Ricart, JM García-Gala, M Lozano
Medicina Clínica (English Edition) 2015
Severe ADAMTS13 Deficiency in Adult Idiopathic Thrombotic Microangiopathies Defines a Subset of Patients Characterized by Various Autoimmune Manifestations, Lower Platelet Count, and Mild Renal Involvement:
P Coppo, D Bengoufa, A Veyradier, M Wolf, A Bussel, GA Millot, S Malot, F Heshmati, JP Mira, E Boulanger, L Galicier, MA Durey-Dragon, V Frémeaux-Bacchi, M Ramakers, A Pruna, D Bordessoule, V Gouilleux, ML Scrobohaci, JP Vernant, D Moreau, E Azoulay, B Schlemmer, L Guillevin, K Lassoued
Medicine 2004
Acute Respiratory Distress Syndrome as a Major Clinical Manifestation of Thrombotic Thrombocytopenic Purpura
JC Chang, ES Aly
The American Journal of the Medical Sciences 2001
Increased plasma von Willebrand factor in the systemic inflammatory response syndrome is derived from generalized endothelial cell activation:
SN McGill, NA Ahmed, NV Christou
Critical Care Medicine 1998
Acquired Von Willebrand Factor Abnormalities in Adults with Congenital Heart Disease: Dependence Upon Cardiopulmonary Pathophysiological Subtype
MC Territo, JK Perloff, MH Rosove, JL Moake, A Runge
Clinical and Applied Thrombosis/Hemostasis 1998
Arteriovenous Fistula Obstruction and Expression of Platelet Receptors for Von Willebrand Factor and for Fibrinogen (Glycoproteins GPIb and GPIIb/llla) in Hemodialysis Patients
M Liani, F Salvati, E Tresca, GD Paolo, L Vitacolonna, M Golato, C Velussi
The International Journal of Artificial Organs 1996
Interaction of Platelet Glycoprotein V with Glycoprotein Ib-IX Regulates Expression of the Glycoproteins and Binding of von Willebrand Factor to Glycoprotein Ib-IX in Transfected Cells
SC Meyer, JE Fox
The Journal of biological chemistry 1995
Characterization of the Unique Mechanism Mediating the Shear-dependent Binding of Soluble von Willebrand Factor to Platelets
S Goto, DR Salomon, Y Ikeda, ZM Ruggeri
The Journal of biological chemistry 1995
Conformational Transitions in the Cell Binding Domain of Fibronectin
TP Ugarova, C Zamarron, Y Veklich, RD Bowditch, MH Ginsberg, JW Weisel, EF Plow
Biochemistry 1995
Platelets and Platelet Inhibitors in Acute Myocardial Infarction
SG Kamat, NS Kleiman
Cardiology Clinics 1995
Abnormal Multimeric and Oligomeric Composition Is Associated With Enhanced Endothelial Expression of von Willebrand Factor in Pulmonary Hypertension
AA Lopes, NY Maeda, VD Aiello, M Ebaid, SP Bydlowski
Chest 1993
Shear-induced platelet aggregation is potentiated by desmopressin and inhibited by ticlopidine
M Cattaneo, R Lombardi, D Bettega, A Lecchi, PM Mannucci
Arteriosclerosis Thrombosis and Vascular Biology 1993

← Previous 1 2 3 … 17 18 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 6 patents
Referenced in 2 clinical guideline sources
131 readers on Mendeley
See more details